MetLife Investment Management’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,276
| Closed | -$113K | – | 2854 |
|
|
2024
Q2 | $113K | Buy |
15,276
+1,434
| +10% | +$10.6K | ﹤0.01% | 2547 |
|
|
2024
Q1 | $108K | Hold |
13,842
| – | – | ﹤0.01% | 2494 |
|
|
2023
Q4 | $70.3K | Hold |
13,842
| – | – | ﹤0.01% | 2734 |
|
|
2023
Q3 | $81.9K | Hold |
13,842
| – | – | ﹤0.01% | 2677 |
|
|
2023
Q2 | $103K | Buy |
+13,842
| New | +$103K | ﹤0.01% | 2666 |
|